Low libido in menopause: causes & what helps

Low libido in menopause

This is not medical advice — it is general information based on what you searched for that may help.

General information based on published sources and the symptoms you searched for. This isn't medical or legal advice, a diagnosis or a treatment plan. Please consult a doctor about your own symptoms. If your symptoms are severe or sudden, seek urgent care.

A drop in sex drive is one of the most common, and most under-discussed, symptoms of menopause. NICE guideline NG23 lists sexual difficulties, including low sexual desire, among the core symptoms associated with menopause — this is a recognized clinical issue, not something you're expected to just live with.

What's actually driving it

Low libido in menopause is rarely one thing. Common, overlapping contributors include:

Vaginal dryness and painful sex: when sex hurts, desire naturally drops — see our vaginal dryness page. Hormone therapy is the most effective treatment for the genitourinary changes behind this.
Sleep loss, fatigue, and low mood: all reduce desire independent of hormones.
Relationship factors and stress, which matter regardless of hormonal status.
Declining testosterone, which, alongside estrogen, contributes to sexual desire in some women.

What can help (graded by evidence)

Option	Evidence grade	What guidelines say
Testosterone supplementation, if HRT alone isn't enough	Moderate	NICE NG23 recommends considering it for low sexual desire associated with menopause; currently an off-label use in the UK, guided by a specialist
Treating vaginal dryness and painful sex directly	Strong	Addressing the physical cause of painful sex, via moisturizers, lubricants, or vaginal estrogen, often restores some desire on its own
"Libido" supplements marketed for menopause	Not supported	No credible clinical trial evidence; check any specific product in our Does It Work? evidence directory before buying it

See our hormone therapy overview for more on how testosterone and HRT are used together, and talk to a clinician before starting it — monitoring and dosing matter.

Prepare for the conversation

A lot of women find this symptom harder to bring up than hot flashes. Our treatment conversation builder can help you organize what you want to say.

Is my low libido more likely linked to vaginal dryness and painful sex, hormone levels, sleep and mood, or some combination?
Would testosterone be appropriate for me if HRT alone doesn't fully address it, and what monitoring would that involve?

Where are you right now?

Still tracking

Not sure if your symptoms fit? Start tracking your daily patterns.

Log and spot your patterns with the symptom checklist →

Ready to talk to a doctor

Have an upcoming appointment? Bring structured questions and your history.

Prepare your 10-minute doctor appointment questions →

Already on treatment

Evaluating your response or wondering what to adjust next?

Explore evidence-graded treatment and lifestyle options →

Questions people ask

Is low sex drive a normal part of menopause?

It's common and recognized in clinical guidance. NICE NG23 lists sexual difficulties, including low sexual desire, among the core symptoms associated with menopause. It's not something you have to simply accept without discussing options, though.

Does testosterone help with low libido in menopause?

NICE guidance recommends considering testosterone for low sexual desire if HRT alone isn't effective. It's currently used off-label for this purpose in the UK, which means a clinician experienced in menopause care should guide the decision, including dose and monitoring.

References

Menopause: identification and management (NG23), Recommendations. National Institute for Health and Care Excellence (UK), 2026.

The 2022 Hormone Therapy Position Statement Advisory Panel. The 2022 hormone therapy position statement of The North American Menopause Society. Menopause (The North American Menopause Society, now The Menopause Society), 2022. Funding: Funded by donations to the NAMS Education & Research Fund; the statement reports no commercial support. Individual panel disclosures not yet reviewed..